SARS-CoV-2 nsp13-IN-5
Modify Date: 2024-01-14 16:34:53
SARS-CoV-2 nsp13-IN-5 structure
|
Common Name | SARS-CoV-2 nsp13-IN-5 | ||
|---|---|---|---|---|
| CAS Number | 912799-11-2 | Molecular Weight | 518.63 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C28H30N4O4S | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of SARS-CoV-2 nsp13-IN-5SARS-CoV-2 nsp13-IN-5 (compound C6) is a potent SARS-CoV-2 nsp13 inhibitor with IC50 values of 50 and 55 μM for ssDNA+ ATPase and ssDNA- ATPase. SARS-CoV-2 nsp13-IN-5 can be used for researching anti-COVID-19[1]. |
| Name | SARS-CoV-2 nsp13-IN-5 |
|---|
| Description | SARS-CoV-2 nsp13-IN-5 (compound C6) is a potent SARS-CoV-2 nsp13 inhibitor with IC50 values of 50 and 55 μM for ssDNA+ ATPase and ssDNA- ATPase. SARS-CoV-2 nsp13-IN-5 can be used for researching anti-COVID-19[1]. |
|---|---|
| Related Catalog | |
| Target |
IC50: 50 μM (ssDNA+ ATPase), 55 μM (ssDNA- ATPase)[1] |
| References |
| Molecular Formula | C28H30N4O4S |
|---|---|
| Molecular Weight | 518.63 |